Zileuton and atopic dermatitis.
Taşkapan
M O
MO
D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D006918:Hydroxyurea / Q000031:analogs & derivatives / Q000627:therapeutic use*; D007073:Immunoglobulin E / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D016896:Treatment Outcome
D007073:Immunoglobulin E; C063449:zileuton; D006918:Hydroxyurea